Approval of ‘Cosentyx,’ a new psoriasis treatment
‘Cosentyx(generic name: secukinumab),’ a Novartis’s new psoriasis treatment, has acquired approval. It is a next-generation new drug which will compete with Janssen’s Stelara.
The Ministry of Food and Drug Safety approved 3 types of medicines, such as Cosentyx, Sensoradipen and Pre-filled Syring...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
